Global Cervical Cancer Test Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.
Scope of the Report:
This report studies the Cervical Cancer Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cervical Cancer Test market by product type and applications/end industries.
Cervical cancer test market is dominated by United States in 2018. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.
A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.
The global Cervical Cancer Test market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cervical Cancer Test.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Scope of the Report:
This report studies the Cervical Cancer Test market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cervical Cancer Test market by product type and applications/end industries.
Cervical cancer test market is dominated by United States in 2018. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.
A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.
The global Cervical Cancer Test market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cervical Cancer Test.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Hologic
- Qiagen N.V.
- Becton, Dickinson and Company
- Hoffman-La Roche
- Abbott Molecular
- Arbor Vita Corporation
- OncoHealth Corporation
- Dell Guided Therapeutics, Inc.
- CooperSurgical, Inc.
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
- Pap Smear Test
- HPV DNA Test
- VIA Test
- Hospitals
- Laboratories
- Physicians’ Offices & Clinics
1 CERVICAL CANCER TEST MARKET OVERVIEW
1.1 Product Overview and Scope of Cervical Cancer Test
1.2 Classification of Cervical Cancer Test by Types
1.2.1 Global Cervical Cancer Test Revenue Comparison by Types (2017-2023)
1.2.2 Global Cervical Cancer Test Revenue Market Share by Types in 2017
1.2.3 Pap Smear Test
1.2.4 HPV DNA Test
1.2.5 VIA Test
1.3 Global Cervical Cancer Test Market by Application
1.3.1 Global Cervical Cancer Test Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Physicians’ Offices & Clinics
1.4 Global Cervical Cancer Test Market by Regions
1.4.1 Global Cervical Cancer Test Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cervical Cancer Test Status and Prospect (2013-2023)
1.5 Global Market Size of Cervical Cancer Test (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Hologic
2.1.1 Business Overview
2.1.2 Cervical Cancer Test Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hologic Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qiagen N.V.
2.2.1 Business Overview
2.2.2 Cervical Cancer Test Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qiagen N.V. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.3 Becton, Dickinson and Company
2.3.1 Business Overview
2.3.2 Cervical Cancer Test Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Becton, Dickinson and Company Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hoffman-La Roche
2.4.1 Business Overview
2.4.2 Cervical Cancer Test Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hoffman-La Roche Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Molecular
2.5.1 Business Overview
2.5.2 Cervical Cancer Test Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Molecular Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.6 Arbor Vita Corporation
2.6.1 Business Overview
2.6.2 Cervical Cancer Test Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Arbor Vita Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.7 OncoHealth Corporation
2.7.1 Business Overview
2.7.2 Cervical Cancer Test Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 OncoHealth Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dell Guided Therapeutics, Inc.
2.8.1 Business Overview
2.8.2 Cervical Cancer Test Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dell Guided Therapeutics, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.9 CooperSurgical, Inc.
2.9.1 Business Overview
2.9.2 Cervical Cancer Test Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CooperSurgical, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CERVICAL CANCER TEST MARKET COMPETITION, BY PLAYERS
3.1 Global Cervical Cancer Test Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cervical Cancer Test Players Market Share
3.2.2 Top 10 Cervical Cancer Test Players Market Share
3.3 Market Competition Trend
4 GLOBAL CERVICAL CANCER TEST MARKET SIZE BY REGIONS
4.1 Global Cervical Cancer Test Revenue and Market Share by Regions
4.2 North America Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.3 Europe Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.5 South America Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CERVICAL CANCER TEST REVENUE BY COUNTRIES
5.1 North America Cervical Cancer Test Revenue by Countries (2013-2018)
5.2 USA Cervical Cancer Test Revenue and Growth Rate (2013-2018)
5.3 Canada Cervical Cancer Test Revenue and Growth Rate (2013-2018)
5.4 Mexico Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6 EUROPE CERVICAL CANCER TEST REVENUE BY COUNTRIES
6.1 Europe Cervical Cancer Test Revenue by Countries (2013-2018)
6.2 Germany Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.3 UK Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.4 France Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.5 Russia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.6 Italy Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CERVICAL CANCER TEST REVENUE BY COUNTRIES
7.1 Asia-Pacific Cervical Cancer Test Revenue by Countries (2013-2018)
7.2 China Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.3 Japan Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.4 Korea Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.5 India Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CERVICAL CANCER TEST REVENUE BY COUNTRIES
8.1 South America Cervical Cancer Test Revenue by Countries (2013-2018)
8.2 Brazil Cervical Cancer Test Revenue and Growth Rate (2013-2018)
8.3 Argentina Cervical Cancer Test Revenue and Growth Rate (2013-2018)
8.4 Colombia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CERVICAL CANCER TEST BY COUNTRIES
9.1 Middle East and Africa Cervical Cancer Test Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.3 UAE Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.4 Egypt Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.6 South Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)
10 GLOBAL CERVICAL CANCER TEST MARKET SEGMENT BY TYPE
10.1 Global Cervical Cancer Test Revenue and Market Share by Type (2013-2018)
10.2 Global Cervical Cancer Test Market Forecast by Type (2018-2023)
10.3 Pap Smear Test Revenue Growth Rate (2013-2023)
10.4 HPV DNA Test Revenue Growth Rate (2013-2023)
10.5 VIA Test Revenue Growth Rate (2013-2023)
11 GLOBAL CERVICAL CANCER TEST MARKET SEGMENT BY APPLICATION
11.1 Global Cervical Cancer Test Revenue Market Share by Application (2013-2018)
11.2 Cervical Cancer Test Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Laboratories Revenue Growth (2013-2018)
11.5 Physicians’ Offices & Clinics Revenue Growth (2013-2018)
12 GLOBAL CERVICAL CANCER TEST MARKET SIZE FORECAST (2018-2023)
12.1 Global Cervical Cancer Test Market Size Forecast (2018-2023)
12.2 Global Cervical Cancer Test Market Forecast by Regions (2018-2023)
12.3 North America Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.4 Europe Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.6 South America Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cervical Cancer Test Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Cervical Cancer Test
1.2 Classification of Cervical Cancer Test by Types
1.2.1 Global Cervical Cancer Test Revenue Comparison by Types (2017-2023)
1.2.2 Global Cervical Cancer Test Revenue Market Share by Types in 2017
1.2.3 Pap Smear Test
1.2.4 HPV DNA Test
1.2.5 VIA Test
1.3 Global Cervical Cancer Test Market by Application
1.3.1 Global Cervical Cancer Test Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Physicians’ Offices & Clinics
1.4 Global Cervical Cancer Test Market by Regions
1.4.1 Global Cervical Cancer Test Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cervical Cancer Test Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cervical Cancer Test Status and Prospect (2013-2023)
1.5 Global Market Size of Cervical Cancer Test (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Hologic
2.1.1 Business Overview
2.1.2 Cervical Cancer Test Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hologic Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qiagen N.V.
2.2.1 Business Overview
2.2.2 Cervical Cancer Test Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qiagen N.V. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.3 Becton, Dickinson and Company
2.3.1 Business Overview
2.3.2 Cervical Cancer Test Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Becton, Dickinson and Company Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.4 Hoffman-La Roche
2.4.1 Business Overview
2.4.2 Cervical Cancer Test Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hoffman-La Roche Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Molecular
2.5.1 Business Overview
2.5.2 Cervical Cancer Test Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Molecular Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.6 Arbor Vita Corporation
2.6.1 Business Overview
2.6.2 Cervical Cancer Test Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Arbor Vita Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.7 OncoHealth Corporation
2.7.1 Business Overview
2.7.2 Cervical Cancer Test Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 OncoHealth Corporation Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dell Guided Therapeutics, Inc.
2.8.1 Business Overview
2.8.2 Cervical Cancer Test Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dell Guided Therapeutics, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
2.9 CooperSurgical, Inc.
2.9.1 Business Overview
2.9.2 Cervical Cancer Test Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CooperSurgical, Inc. Cervical Cancer Test Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CERVICAL CANCER TEST MARKET COMPETITION, BY PLAYERS
3.1 Global Cervical Cancer Test Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cervical Cancer Test Players Market Share
3.2.2 Top 10 Cervical Cancer Test Players Market Share
3.3 Market Competition Trend
4 GLOBAL CERVICAL CANCER TEST MARKET SIZE BY REGIONS
4.1 Global Cervical Cancer Test Revenue and Market Share by Regions
4.2 North America Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.3 Europe Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.5 South America Cervical Cancer Test Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CERVICAL CANCER TEST REVENUE BY COUNTRIES
5.1 North America Cervical Cancer Test Revenue by Countries (2013-2018)
5.2 USA Cervical Cancer Test Revenue and Growth Rate (2013-2018)
5.3 Canada Cervical Cancer Test Revenue and Growth Rate (2013-2018)
5.4 Mexico Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6 EUROPE CERVICAL CANCER TEST REVENUE BY COUNTRIES
6.1 Europe Cervical Cancer Test Revenue by Countries (2013-2018)
6.2 Germany Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.3 UK Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.4 France Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.5 Russia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
6.6 Italy Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CERVICAL CANCER TEST REVENUE BY COUNTRIES
7.1 Asia-Pacific Cervical Cancer Test Revenue by Countries (2013-2018)
7.2 China Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.3 Japan Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.4 Korea Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.5 India Cervical Cancer Test Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CERVICAL CANCER TEST REVENUE BY COUNTRIES
8.1 South America Cervical Cancer Test Revenue by Countries (2013-2018)
8.2 Brazil Cervical Cancer Test Revenue and Growth Rate (2013-2018)
8.3 Argentina Cervical Cancer Test Revenue and Growth Rate (2013-2018)
8.4 Colombia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CERVICAL CANCER TEST BY COUNTRIES
9.1 Middle East and Africa Cervical Cancer Test Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.3 UAE Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.4 Egypt Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cervical Cancer Test Revenue and Growth Rate (2013-2018)
9.6 South Africa Cervical Cancer Test Revenue and Growth Rate (2013-2018)
10 GLOBAL CERVICAL CANCER TEST MARKET SEGMENT BY TYPE
10.1 Global Cervical Cancer Test Revenue and Market Share by Type (2013-2018)
10.2 Global Cervical Cancer Test Market Forecast by Type (2018-2023)
10.3 Pap Smear Test Revenue Growth Rate (2013-2023)
10.4 HPV DNA Test Revenue Growth Rate (2013-2023)
10.5 VIA Test Revenue Growth Rate (2013-2023)
11 GLOBAL CERVICAL CANCER TEST MARKET SEGMENT BY APPLICATION
11.1 Global Cervical Cancer Test Revenue Market Share by Application (2013-2018)
11.2 Cervical Cancer Test Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Laboratories Revenue Growth (2013-2018)
11.5 Physicians’ Offices & Clinics Revenue Growth (2013-2018)
12 GLOBAL CERVICAL CANCER TEST MARKET SIZE FORECAST (2018-2023)
12.1 Global Cervical Cancer Test Market Size Forecast (2018-2023)
12.2 Global Cervical Cancer Test Market Forecast by Regions (2018-2023)
12.3 North America Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.4 Europe Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.6 South America Cervical Cancer Test Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cervical Cancer Test Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Cervical Cancer Test Picture
Table Product Specifications of Cervical Cancer Test
Table Global Cervical Cancer Test and Revenue (Million USD) Market Split by Product Type
Figure Global Cer
Figure Cervical Cancer Test Picture
Table Product Specifications of Cervical Cancer Test
Table Global Cervical Cancer Test and Revenue (Million USD) Market Split by Product Type
Figure Global Cer
